General description
36 kDa
CD79beta is restricted to the B-cell lineage, and is found in pro-B cells before Ig heavy-chain gene rearrangement but after CD79alpha expression. The antibody reacts with an epitope on the extracellular domain of CD79 (Yoshida, 1995). Anti-CD79beta, SN8, was included in the Fifth International Workshop and Conference on Human Leucocyte Differentiation Antigens, and studies by a number of laboratories confirmed its reactivity with CD79beta (Engel, 1995; Persin, 1995).
Application
Milli-Mark Anti-CD79β-FITC Antibody, clone SN8 detects level of CD79β & has been published & validated for use in FC.
Biochem/physiol Actions
Antibody recognizes Human CD79b antigen.
Analysis Note
Evaluated by flow cytometry using human lymphocytess
Legal Information
MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany
| biological source | mouse |
| Quality Segment | 100 |
| conjugate | FITC conjugate |
| antibody form | purified antibody |
| antibody product type | primary antibodies |
| clone | SN8, monoclonal |
| species reactivity | human |
| manufacturer/tradename | Milli-Mark® |
| technique(s) | flow cytometry: suitable |
| isotype | IgG1κ |
| NCBI accession no. | NP_000617 |
| UniProt accession no. | P40259 |
| shipped in | wet ice |
| target post-translational modification | unmodified |
| Gene Information | human ... CD79B(974) |
